Vienna-based healthtech scale-up XUND secures pre-Series A, led by Budapest-based Lead Ventures.
👯 Founders: Tamás Petrovics (CEO), Tamás Petrovics, Lukas Seper, Dr. Zoltán Tarabó
📅 Founding year: 2018
🏭 Industry: Healthtech
💥 Problem: There are high walls between new technologies and legacy healthcare systems. The patient journey needs to be digitized to enhance patient care but also streamline operations for healthcare providers.
📣 Solution: AI-powered Software as a Medical Device (SaMD), including MDR-certified technology and RAVE, a cutting-edge large language model (LLM) solution.
👥 Customers: Healthcare providers, patients, and European healthcare systems.
🌱 Stage: Pre-Series A
💰 Investment amount: €6M
🚀 Funded by: Lead Ventures, J&T Ventures, MassMutual Ventures, tba network, LANA Ventures
👁️🗨️ Investor’s perspective:
“We are thrilled to partner with XUND, a company that brings clarity to the most important decisions in healthcare. Their commitment to digitizing the patient journey not only enhances patient care but also streamlines operations for healthcare providers. The long-anticipated synthesis of AI technology in patient care is finally happening widely and it is truly exciting to bring down the walls between new technologies and legacy healthcare systems. We have immense confidence in XUND’s team and vision, and are eager to support their bold expansion efforts to transform healthcare delivery,” said Balázs Haszonics, Managing Partner at Lead Ventures.
💡 It will be spent on: Accelerating expansion in DACH and the UK, advancing MDR-certified solutions, and integrating the RAVE large language model for personalized healthcare systems.
💬 In their own words:
“This investment is a testament to our hard work, and it will help us accelerate our European expansion and advance the integration of our medical devices and RAVE solution, reshaping healthcare delivery.” – Tamás Petrovics, Co-Founder and CEO.
💪 Their specialty: AI-powered medical technology, SaMD, and AI-driven digital health solutions.
🔑 Business model: Developing and deploying MDR-certified software as medical devices (SaMD), with a focus on AI integration for personalized healthcare.
👩🏫 Market: Europe, with a focus on DACH and the UK, positioning for global scale.
📈 Funding so far: €9.35M
